Routine hepatitis B immunisation in India: cost-effectiveness assessment.
dc.contributor.author | Miller, M A | en_US |
dc.contributor.author | Kane, M | en_US |
dc.date.accessioned | 2000-04-06 | en_US |
dc.date.accessioned | 2009-05-30T13:28:33Z | |
dc.date.available | 2000-04-06 | en_US |
dc.date.available | 2009-05-30T13:28:33Z | |
dc.date.issued | 2000-04-06 | en_US |
dc.description.abstract | Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health. | en_US |
dc.description.affiliation | Research Fogarty International Center NIH, Bethesda, MD 20892-2220, USA. millermark@who.ch | en_US |
dc.identifier.citation | Miller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian Journal of Pediatrics. 2000 Apr; 67(4): 299-300 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/81723 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://medind.nic.in/icb/icbai.shtml | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Cost-Benefit Analysis | en_US |
dc.subject.mesh | Hepatitis B Vaccines --economics | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunization Programs | en_US |
dc.subject.mesh | India | en_US |
dc.title | Routine hepatitis B immunisation in India: cost-effectiveness assessment. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1